How GLP-1s Work for Weight Loss: A Clear UK Guide

Published on: July 3, 2026

Medically reviewed by

Ashis Tandukar

Superintendent Pharmacist · Reg: GPhC No. 2084170

Most people come to this question after hearing a friend, a colleague, or half of the internet talk about weight loss injections. Mounjaro. Wegovy. Ozempic. The names get used almost interchangeably, and underneath them all sits the same three-letter term: GLP-1. What it means, and why it seems to help people eat less without the old white-knuckle willpower, is rarely explained properly.

So let's slow down and go through it the way we would in a consultation — no jargon left unexplained, no overselling.

What GLP-1 actually is

GLP-1 stands for glucagon-like peptide-1. It's a hormone your own gut makes — specifically from cells lining the small intestine — and it's released within minutes of food arriving. It belongs to a family called the incretins, chemical messengers that help your body respond sensibly to a meal.

In its natural form, GLP-1 has one big limitation: it disappears almost instantly. An enzyme called DPP-4 breaks it down within a minute or two of release. That's fine for its everyday job of nudging your body through a single meal, but it means the natural hormone was never going to be a useful medicine on its own.

The breakthrough was chemical. Scientists worked out how to redesign the GLP-1 molecule so the body's enzymes can't dismantle it as quickly. The result is a version that survives for days rather than minutes — which is why a single weekly injection can keep working across seven days.

How GLP-1 medications work in the body

When people ask how GLP-1s work, they usually imagine a single "switch". It's more like three levers being pulled gently at once. Each one matters, and together they explain most of what patients actually experience.

They turn down appetite in the brain

This is the effect people notice first, and it's the one that surprises them most. GLP-1 receptors sit in the appetite-regulating regions of the brain — the hypothalamus and parts of the brainstem. When the medication activates them, the brain registers a stronger, earlier sense of fullness and a weaker drive to eat.

Patients rarely describe this as feeling forced. They describe it as the background chatter going quiet. That constant low hum of thinking about the next snack, the leftover biscuits, what's in the fridge — it fades. There's even a name for that hum now: food noise. For a lot of people, turning it down is the single most freeing part of treatment.

They slow how fast the stomach empties

GLP-1 also tells the stomach to take its time. Food moves out of the stomach and into the intestine more slowly, so you stay physically fuller for longer after eating.

Two things follow from that. Portions that used to feel normal start to feel like too much, and the gap before you're hungry again stretches out. It's also the reason a heavy, greasy meal can sit uncomfortably on treatment — the stomach simply isn't clearing it as quickly as it once did.

They help the pancreas manage blood sugar

The third lever is metabolic. GLP-1 prompts the pancreas to release insulin when blood sugar is high, and it quietens the release of glucagon, a hormone that pushes blood sugar up. This steadies the glucose swings that can drive hunger and cravings.

There's an elegant safety feature built into this. GLP-1 only encourages insulin release when blood sugar is actually raised — it's glucose-dependent. That's why, used on their own, these medications carry a low risk of dropping your blood sugar too far. This blood-sugar action is also why the same drugs were originally developed for type 2 diabetes, long before weight management.

Why one injection lasts a whole week

A fair question: if the natural hormone vanishes in minutes, how does an injection keep working for seven days?

The answer is in the redesign. Both semaglutide and tirzepatide are built to resist the DPP-4 enzyme and to cling to a blood protein called albumin, which keeps them circulating instead of being cleared. Semaglutide has a half-life of around a week; tirzepatide's is roughly five days. Practically, that means a steady level of medication in your system, one injection at a time, on the same day each week. It also means the effect doesn't switch off the moment you're a few hours late — though consistency still matters for how quickly things settle into a rhythm.

GLP-1 alone vs GLP-1 plus GIP

Here's where the popular names start to matter, because not every "weight loss injection" works in exactly the same way.

Semaglutide — sold as Wegovy for weight management and Ozempic for diabetes — is a pure GLP-1 receptor agonist. It pulls the three levers above.

Tirzepatide — sold as Mounjaro — pulls those same GLP-1 levers but adds a second one. It also activates the receptor for GIP, another incretin hormone that plays a role in how the body handles fat and blood sugar. Acting on both pathways at once appears to produce a bigger effect on appetite and weight, which is reflected in the trial data.

Those trial figures are averages from large studies, alongside diet and activity support. They're a guide to what the medications can do — not a promise of what any one person will lose. Individual results vary widely, and they depend heavily on the changes made around the medication. If you're weighing up the two, we go deeper in Wegovy vs Mounjaro.

What this feels like in real life

Mechanisms are one thing. What actually changes day to day is another, and it's worth being honest about both the good and the awkward.

The good: smaller portions genuinely satisfy you, cravings lose their grip, and the mental energy you used to spend negotiating with yourself about food gets handed back. Many people say the first clear sign something has shifted isn't the scales at all — it's realising they left food on the plate without thinking about it.

The awkward: because the stomach empties more slowly, rich or large meals can cause nausea, and some people feel it in the first days after each dose step-up. Alcohol can hit differently. And appetite suppression can make it easy to under-eat protein, which is why protecting muscle — through enough protein and some resistance movement — matters more than people expect. We cover that in maintaining muscle on GLP-1 medications.

Why they work when dieting alone often hasn't

If you've lost weight before and watched it creep back, it's easy to read that as a personal failing. It usually isn't. It's biology doing exactly what it evolved to do.

When you lose weight by eating less, your body fights back. Hunger hormones such as ghrelin rise, fullness signals dip, and your appetite ramps up to pull you back to where you started. This is part of why willpower feels like it runs out — you're not weak, you're outnumbered by a system built to defend body fat. That defence can persist for months, long after the diet ended.

GLP-1 medications work on the same hormonal machinery that's driving the fight. Instead of asking you to override a hungry brain by force, they lower the hunger signal itself. That's the real shift. The effort of eating less stops feeling like a daily act of self-denial and starts feeling, for many people, almost unremarkable. Same goal, very different experience — and a far more sustainable one while treatment continues. If appetite has been your sticking point, our guide to appetite suppressants puts GLP-1s in context alongside the other options.

What GLP-1 medications don't do

This is the part that gets lost in the hype, and it's the part worth reading twice.

These drugs don't override the basics. They make eating less feel achievable, but the weight comes off because you're taking in less energy than you're using — the medication just makes that far less of a daily battle. Food quality still counts. Movement still counts. Sleep and stress still count.

They also aren't a short course. GLP-1 medications manage appetite while you take them; they don't permanently reset it. When people stop, appetite tends to return, and without other changes in place, some or most of the weight can come back. That's not a failure of the drug — it's a reflection of the fact that obesity behaves like a chronic condition, not a one-off problem to be fixed and forgotten.

None of this means the medication is a shortcut or a cheat. It means it's a clinical tool that works best inside a bigger picture — one a good service builds with you, rather than handing you a pen and waving you off.

Are they right for everyone?

No — and a responsible service will tell you so before it takes your money. GLP-1 medications for weight management are licensed with clear criteria, generally around body mass index and weight-related health conditions, and they aren't suitable for everyone.

They're not recommended in pregnancy or while breastfeeding, and there are specific situations — a personal or family history of certain thyroid cancers, some pancreatic conditions — where they're avoided or need careful thought. Other medications, including the contraceptive pill, can interact with the slowed stomach emptying. This is exactly why a proper medical assessment comes first, rather than a tick-box form. If you want to see how the different injectable options compare before that conversation, our guide to weight loss injections in the UK is a good place to start. For a closer look at the receptor-level detail behind one of them, there's also how Mounjaro affects hormones, hunger and the brain.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.